3-(phenoxyphenylmethyl)pyrrolidine compounds

Details 3-(phenoxyphenylmethyl)pyrrolidine compounds 3-(phenoxyphenylmethyl)pyrrolidine compounds

2011-02-15

2011-02-15

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S570000, C548S571000

Reexamination Certificate

active

07888386

ABSTRACT:
In one aspect, the invention relates to compounds of formula I:where a and R1-6are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

REFERENCES:
patent: 3634437 (1972-01-01), Todd
patent: 4229449 (1980-10-01), Melloni et al.
patent: 4243807 (1981-01-01), Friebe et al.
patent: 5023269 (1991-06-01), Robertson et al.
patent: 5037841 (1991-08-01), Schobe et al.
patent: 5614518 (1997-03-01), Leeson et al.
patent: 6518284 (2003-02-01), Orjales Venero et al.
patent: 7294637 (2007-11-01), Aquila et al.
patent: 7317011 (2008-01-01), Wong et al.
patent: 7378436 (2008-05-01), Fish et al.
patent: 7384941 (2008-06-01), Walter et al.
patent: 2005/0245519 (2005-11-01), Barta et al.
patent: 2005/0250775 (2005-11-01), Fish et al.
patent: 2007/0015786 (2007-01-01), Allen et al.
patent: 2007/0072859 (2007-03-01), Boulet et al.
patent: 2007/0265306 (2007-11-01), Venero et al.
patent: 2008/0153919 (2008-06-01), Kranzler et al.
patent: 00/56318 (2000-09-01), None
patent: 2006/099433 (2006-09-01), None
patent: 2007/031828 (2007-03-01), None
patent: 2008/023258 (2008-02-01), None
STN-12507965—07282010.
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for PCT/US2009/051496.
Murphy et al., “The Synthesis and Biological Evaluation of Novel Series of Nitrile-containing Fluoroquinolones as Antibacterial Agents”, Bioorganic & Medicinal Chemistry Letters, 17, pp. 2150-2155 (2007).
Fish et al., “Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition”, Bioorganic & Medicinal Chemistry Letters, 18, pp. 2562-2566, 2008.
Fish et al., “Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity”, Bioorganic & Medicinal Chemistry Letters, 18, pp. 4355-4359, 2008.
Fish et al., “4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure-activity relationships”, Bioorganic & Medicinal Chemistry Letters, 19, pp. 2829-2834, 2009.
Melloni et al., “Potential antidepressant agents. Alpha-aryloxy-benzyl derivatives of ethanolamine and morpholine”, European Journal of Medicinal Chemistry, 19(3), pp. 235-242, 1984.
Orjales et al., “Synthesis and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters”, Journal of Medicinal Chemistry, 46, pp. 5512-5532, 2003.
U.S. Appl. No. 12/760,276, Stangeland et al.
U.S. Appl. No. 12/834,128, Stangeland et al.
U.S. Appl. No. 12/835,944, Stangeland et al.

Affiliated with

Also associated with

Rating

3-(phenoxyphenylmethyl)pyrrolidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-(phenoxyphenylmethyl)pyrrolidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(phenoxyphenylmethyl)pyrrolidine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2642024